Other Species / Isoforms
  FEZ1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S58-p
SEIISFKsMEDLVNE
Upstream
Downstream
2 7
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Kinase, in vitro:
  • MARK1 (human)
  • MARK2 (human)
  • MARK3 (human)
Putative in vivo kinases:
  • MARK1 (human)
  • MARK2 (human)
  • MARK3 (human)
Treatment
  • virus infection
FEZ1 (human) SEIISFKsMEDLVNE S58-p
FEZ1 (mouse) SEIISFKsMEDLVNE S58-p
FEZ1 (rat) SEIISFKsMEDLVNE S58-p
S247-p
EGAIRDFsEELVQQL
0 2
FEZ1 (human) EGAIRDFsEELVQQL S247-p
FEZ1 (mouse) EGAIRDFSEELVHQL S247
FEZ1 (rat) EGAIRDFSEELVHQL S248
S298-p
RRKEKGLsLQsSRIE
0 7
FEZ1 (human) RRKEKGLsLQsSRIE S298-p
FEZ1 (mouse) RRKEKGLsLQSNRIE S298-p
FEZ1 (rat) RRKEKGLsLQSSRIE S299-p
S301-p
EKGLsLQsSRIEKGN
0 1
FEZ1 (human) EKGLsLQsSRIEKGN S301-p
FEZ1 (mouse) EKGLsLQSNRIEKGS S301
FEZ1 (rat) EKGLsLQSSRIEKGN S302
S316-p
QMPLKRFsMEGISNI
Upstream
0 8
Treatment
  • LRRK2-IN-1
FEZ1 (human) QMPLKRFsMEGISNI S316-p
FEZ1 (mouse) QMPLKRFsMEGISNI S316-p
FEZ1 (rat) QMPLKRFSMEGISNI S317
Y341-p
SSGTDKQyLNtVIPy
0 2
FEZ1 (human) SSGTDKQyLNtVIPy Y341-p
FEZ1 (mouse) SSGADRQYLNTVIPY Y341
FEZ1 (rat) SSGADRQYLNTVIPY Y342
T344-p
TDKQyLNtVIPyEKK
0 1
FEZ1 (human) TDKQyLNtVIPyEKK T344-p
FEZ1 (mouse) ADRQYLNTVIPYEKK T344
FEZ1 (rat) ADRQYLNTVIPYEKK T345
Y348-p
yLNtVIPyEKKASPP
0 2
FEZ1 (human) yLNtVIPyEKKASPP Y348-p
FEZ1 (mouse) YLNTVIPYEKKSSPP Y348
FEZ1 (rat) YLNTVIPYEKKSSPP Y349
K376
AMKEDNEKVPTLLTD
0 1
FEZ1 (human) AMKEDNEKVPTLLTD K376
FEZ1 (mouse) AMKEDNEkVPTLLTD K376-ub
FEZ1 (rat) AMKEDNEKVPTLLTD K377